Clinical Trials · NCT04167163
Abaloparatide Before Total Knee Arthroplasty
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Wisconsin, Madison
- Enrollment
- 58
- Start date
- Jan 2020
- Locations
- 1 site, United States
- Primary endpoint
- Change in Distal Femoral Bone Mineral Density (BMD) at the 25% Regions of Interest (ROIs)